Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephanie Goletz

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
The American Journal of Pathology|July 22, 2014
Fcγ receptors III and IV mediate tissue destruction in a novel adult mouse model of bullous pemphigoidFranziska S Schulze, Tina Beckmann, Falk Nimmerjahn, et al.
Frontiers in Immunology|September 21, 2018
Immunoadsorption of Desmoglein-3-Specific IgG Abolishes the Blister-Inducing Capacity of Pemphigus Vulgaris IgG in Neonatal MiceMaxi Hofrichter, Jenny Dworschak, Shirin Emtenani, et al.
The Journal of Investigative Dermatology|May 1, 2017
Experimental Laminin 332 Mucous Membrane Pemphigoid Critically Involves C5aR1 and Reflects Clinical and Immunopathological Characteristics of the Human DiseaseEva Nina Heppe, Sabrina Tofern, Franziska S Schulze, et al.
The Journal of Investigative Dermatology|June 7, 2022
Anti-BP230 Only Bullous Pemphigoid Constitutes a Distinct Disease Subgroup with Characteristic Serological and Clinical FeaturesTorben Ramcke, Vanessa Bolduan, Elisabeth Vicari, et al.
Acta Dermato-Venereologica|March 9, 2021
Diagnosis of Epidermolysis Bullosa Acquisita: Multicentre Comparison of Different Assays for Serum Anti-type VII Collagen ReactivityMaike M Holtsche, Nina van Beek, Takashi Hashimoto, et al.
Frontiers in Immunology|December 13, 2021
Comparison of Two Diagnostic Assays for Anti-Laminin 332 Mucous Membrane PemphigoidStephanie Goletz, Federica Giurdanella, Maike M Holtsche, et al.
The British Journal of Dermatology|March 28, 2024
Sensitive and specific assay for the serological diagnosis of anti-p200 pemphigoid based on the recombinant laminin β4 subunitStephanie Goletz, Christian Probst, Lars Komorowski, et al.
The Journal of Investigative Dermatology|October 22, 2021
Pathogenic Autoantibody Derived from Regulatory T Cell‒Deficient Scurfy Mice Targets Type VII Collagen and Leads to Epidermolysis Bullosa Acquisita‒Like Blistering DiseaseElisabeth Vicari, Stefanie Haeberle, Vanessa Bolduan, et al.
The British Journal of Dermatology|February 27, 2026
Comparative performance of four immunoassays for anti-laminin 332 serum IgG in mucous membrane pemphigoid: a multicentre prospective blinded studyStephanie Goletz, Norito Ishii, Charlotte Kiehne, et al.
The Journal of Investigative Dermatology|November 18, 2021
Multiple Modes of Action Mediate the Therapeutic Effect of Intravenous IgG in Experimental Epidermolysis Bullosa AcquisitaElena Pipi, Anika Kasprick, Hiroaki Iwata, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
The American Journal of Pathology|July 22, 2014
Fcγ receptors III and IV mediate tissue destruction in a novel adult mouse model of bullous pemphigoidFranziska S Schulze, Tina Beckmann, Falk Nimmerjahn, et al.
Frontiers in Immunology|September 21, 2018
Immunoadsorption of Desmoglein-3-Specific IgG Abolishes the Blister-Inducing Capacity of Pemphigus Vulgaris IgG in Neonatal MiceMaxi Hofrichter, Jenny Dworschak, Shirin Emtenani, et al.
The Journal of Investigative Dermatology|May 1, 2017
Experimental Laminin 332 Mucous Membrane Pemphigoid Critically Involves C5aR1 and Reflects Clinical and Immunopathological Characteristics of the Human DiseaseEva Nina Heppe, Sabrina Tofern, Franziska S Schulze, et al.
The Journal of Investigative Dermatology|June 7, 2022
Anti-BP230 Only Bullous Pemphigoid Constitutes a Distinct Disease Subgroup with Characteristic Serological and Clinical FeaturesTorben Ramcke, Vanessa Bolduan, Elisabeth Vicari, et al.
Acta Dermato-Venereologica|March 9, 2021
Diagnosis of Epidermolysis Bullosa Acquisita: Multicentre Comparison of Different Assays for Serum Anti-type VII Collagen ReactivityMaike M Holtsche, Nina van Beek, Takashi Hashimoto, et al.
Frontiers in Immunology|December 13, 2021
Comparison of Two Diagnostic Assays for Anti-Laminin 332 Mucous Membrane PemphigoidStephanie Goletz, Federica Giurdanella, Maike M Holtsche, et al.
The British Journal of Dermatology|March 28, 2024
Sensitive and specific assay for the serological diagnosis of anti-p200 pemphigoid based on the recombinant laminin β4 subunitStephanie Goletz, Christian Probst, Lars Komorowski, et al.
The Journal of Investigative Dermatology|October 22, 2021
Pathogenic Autoantibody Derived from Regulatory T Cell‒Deficient Scurfy Mice Targets Type VII Collagen and Leads to Epidermolysis Bullosa Acquisita‒Like Blistering DiseaseElisabeth Vicari, Stefanie Haeberle, Vanessa Bolduan, et al.
The British Journal of Dermatology|February 27, 2026
Comparative performance of four immunoassays for anti-laminin 332 serum IgG in mucous membrane pemphigoid: a multicentre prospective blinded studyStephanie Goletz, Norito Ishii, Charlotte Kiehne, et al.
The Journal of Investigative Dermatology|November 18, 2021
Multiple Modes of Action Mediate the Therapeutic Effect of Intravenous IgG in Experimental Epidermolysis Bullosa AcquisitaElena Pipi, Anika Kasprick, Hiroaki Iwata, et al.
Pageof 4